Immatics Biotechnologies GmbH (NASDAQ:IMTXW) Sees Large Increase in Short Interest
Immatics Biotechnologies GmbH (NASDAQ:IMTXW) Sees Large Increase in Short Interest
immatics biotechnologies GmbH (NASDAQ:IMTXW – Get Rating) was the target of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 17,400 shares, a growth of 6.1% from the March 15th total of 16,400 shares. Based on an average daily trading volume, of 5,900 shares, the days-to-cover ratio is presently 2.9 days.
immatics biotechnologies GmbH(納斯達克股票代碼:IMTXW — 獲取評級)是3月份空頭利息大幅增長的目標。截至3月31日,空頭利息總額爲17,400股,較3月15日的16,400股增長了6.1%。根據5,900股的平均每日交易量,目前的回報天數爲2.9天。
immatics biotechnologies Price Performance
immatics 生物技術價格表現
Shares of IMTXW stock opened at $1.53 on Friday. immatics biotechnologies has a twelve month low of $0.88 and a twelve month high of $4.41. The stock has a fifty day moving average price of $1.80.
IMTXW股票週五開盤價爲1.53美元。immatics biotechnologies創下十二個月低點0.88美元,創十二個月高點4.41美元。該股的五十天移動平均價格爲1.80美元。
Institutional Investors Weigh In On immatics biotechnologies
機構投資者關注immatics生物技術
Several hedge funds have recently made changes to their positions in the company. Virtu Financial LLC purchased a new stake in shares of immatics biotechnologies during the 4th quarter worth $28,000. Jefferies Financial Group Inc. purchased a new stake in shares of immatics biotechnologies during the 4th quarter worth $80,000. Alyeska Investment Group L.P. purchased a new stake in shares of immatics biotechnologies during the 4th quarter worth $529,000. Finally, Aristeia Capital LLC lifted its stake in shares of immatics biotechnologies by 3,293.6% during the 4th quarter. Aristeia Capital LLC now owns 754,590 shares of the company's stock worth $1,856,000 after purchasing an additional 732,354 shares during the last quarter.
幾家對沖基金最近改變了他們在公司的頭寸。Virtu Financial LLC在第四季度收購了價值28,000美元的immatics biotechnologies股票的新股份。傑富瑞金融集團公司在第四季度收購了價值8萬美元的immatics biotechnologies股票的新股份。Alyeska Investment Group L.P. 在第四季度購買了價值52.9萬美元的immatics biotechnologies股票的新股份。最後,Aristeia Capital LLC在第四季度將其在immatics biotechnologies的股份增加了3,293.6%。Aristeia Capital LLC在上個季度又購買了732,354股股票後,現在擁有該公司754,590股股票,價值18.56萬美元。
See Also
另請參閱
- Get a free copy of the StockNews.com research report on immatics biotechnologies (IMTXW)
- MarketBeat Week in Review – 4/17 – 4/21
- 2 Industrial Strength Dividend Stocks Melting Up
- Proctor & Gamble Is Going To Set A New High
- AutoNation's Plans are Keeping Analysts Around
- Netflix Increases Buybacks: Can It Complete A Reversal In 2023?
- 免費獲取 StockNews.com immatics 生物技術 (IMTXW) 研究報告
- MarketBeat 週迴顧 — 4 月 17 日 — 4 月 21 日
- 2 只工業實力股息股票正在融化
- 寶潔將創下新高
- AutoNation的計劃讓分析師待在身邊
- Netflix 增加回購:它能否在 2023 年完成逆轉?
Receive News & Ratings for immatics biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for immatics biotechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收有關immatics生物技術的新聞和評級 -在下面輸入您的電子郵件地址,通過Marketbeat.com的免費每日電子郵件時事通訊,獲取有關immatics biotechnologies及相關公司的最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。